SCHEMBL6467183

SCHEMBL6467183

Oc1ncnc2c1ncn2C1CCCCCC1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 4/20 0.68
▸ PI4KA P42356 4/20 0.68
▸ PI4K2B Q8TCG2 4/20 0.68
▸ PI4K2A Q9BTU6 4/20 0.68
▸ PI4KB Q9UBF8 4/20 0.68
▸ ADORA3 P0DMS8 2/20 0.65
▸ ADORA1 P30542 2/20 0.65
▸ ADORA2B P29275 1/20 0.60
▸ NFKB1 P19838 2/20 0.57
▸ BLM P54132 2/20 0.57
▸ CYP1A2 P05177 1/20 0.57
▸ CYP3A4 P08684 1/20 0.57
▸ THPO P40225 1/20 0.57
▸ SMN1; SMN2 Q16637 1/20 0.57
▸ TDP1 Q9NUW8 1/20 0.57
▸ YTHDC1 Q96MU7 1/20 0.51
▸ CTSL P07711 2/20 0.41
▸ CTSS P25774 1/20 0.41
▸ CTSB P07858 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11400740 0.81 ADORA2A (0.68) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL3245641 0.81 ADORA2A (1.00) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL12143426 0.79 ADORA2A (0.67) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL978424 0.79 ADORA2A (1.00) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL12844563 0.78 ADORA2A (0.61) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL10394463 0.77 ADCY5 (0.55) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL21435666 0.75 ADORA2A (1.00) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL24708227 0.75 YTHDC1 (0.88) ADORA2API4KAPI4K2BPI4K2API4KB
Methyl Alcohol SCHEMBL10438261 0.75 ADORA2A (0.91) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL12775424 0.75 ADORA2A (0.61) ADORA2API4KAPI4K2BPI4K2API4KB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065171-A1 Substituted purine derivatives ARIAD PHARMACEUTICALS, INC. 2005-03-24 — — US disclosed
WO-2005009348-A2 SUBSTITUTED PURINE DERIVATIVES ARIAD PHARMACEUTICALS, INC. (US) 2005-02-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065171-A1 Substituted purine derivatives ADORA2A, PNP, HPRT1 ADORA2A 1/4885PI4KA 4241/4885PI4K2B 4237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback